Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.

Hyponatremia and decreased bone density in adolescent inpatients diagnosed with anorexia nervosa.

Levy-Shraga Y, David D, Vered I, Kochavi B, Stein D, Modan-Moses D.

Nutrition. 2016 Oct;32(10):1097-102. doi: 10.1016/j.nut.2016.03.015. Epub 2016 Mar 25.

PMID:
27222345
2.

Attenuated Weight Gain with the Novel Analog of Olanzapine Linked to Sarcosinyl Moiety (PGW5) Compared to Olanzapine.

Taler M, Vered I, Globus R, Shbiro L, Weizman A, Weller A, Gil-Ad I.

J Mol Neurosci. 2016 Jan;58(1):66-73. doi: 10.1007/s12031-015-0679-2. Epub 2015 Nov 14.

PMID:
26572534
3.

Maternal and infantile hypercalcemia caused by vitamin-D-hydroxylase mutations and vitamin D intake.

Dinour D, Davidovits M, Aviner S, Ganon L, Michael L, Modan-Moses D, Vered I, Bibi H, Frishberg Y, Holtzman EJ.

Pediatr Nephrol. 2015 Jan;30(1):145-52. doi: 10.1007/s00467-014-2889-1. Epub 2014 Sep 7.

PMID:
25194629
4.

High prevalence of vitamin D deficiency and insufficiency in adolescent inpatients diagnosed with eating disorders.

Modan-Moses D, Levy-Shraga Y, Pinhas-Hamiel O, Kochavi B, Enoch-Levy A, Vered I, Stein D.

Int J Eat Disord. 2015 Sep;48(6):607-14. doi: 10.1002/eat.22347. Epub 2014 Aug 18.

PMID:
25130505
5.

The effect of continuous subcutaneous recombinant PTH (1-34) infusion during pregnancy on calcium homeostasis - a case report.

Ilany J, Vered I, Cohen O.

Gynecol Endocrinol. 2013 Sep;29(9):807-10. doi: 10.3109/09513590.2013.813473. Epub 2013 Jul 18.

PMID:
23865697
6.

Glyoxylate carboligase: a unique thiamin diphosphate-dependent enzyme that can cycle between the 4'-aminopyrimidinium and 1',4'-iminopyrimidine tautomeric forms in the absence of the conserved glutamate.

Nemeria N, Binshtein E, Patel H, Balakrishnan A, Vered I, Shaanan B, Barak Z, Chipman D, Jordan F.

Biochemistry. 2012 Oct 9;51(40):7940-52. doi: 10.1021/bi300893v. Epub 2012 Sep 25.

7.

DNA damage bypass operates in the S and G2 phases of the cell cycle and exhibits differential mutagenicity.

Diamant N, Hendel A, Vered I, Carell T, Reissner T, de Wind N, Geacinov N, Livneh Z.

Nucleic Acids Res. 2012 Jan;40(1):170-80. doi: 10.1093/nar/gkr596. Epub 2011 Sep 9.

8.

Quantification of human serum procollagen C-proteinase enhancer (hsPCPE) glycopattern.

Olswang-Kuz Y, Liberman B, Weiss I, Ramu E, Weitzen R, Vered I, Gat-Yablonski G, Kessler E, Anikster Y, Mesilaty-Gross S.

Clin Chim Acta. 2011 Sep 18;412(19-20):1762-6. doi: 10.1016/j.cca.2011.04.030. Epub 2011 May 4.

PMID:
21569766
9.

Once-yearly zoledronic acid and days of disability, bed rest, and back pain: randomized, controlled HORIZON Pivotal Fracture Trial.

Cauley JA, Black D, Boonen S, Cummings SR, Mesenbrink P, Palermo L, Man Z, Hadji P, Reid IR; HORIZON Pivotal Fracture Group..

J Bone Miner Res. 2011 May;26(5):984-92. doi: 10.1002/jbmr.292.

10.

Measurement of circulating cell-free DNA levels by a new simple fluorescent test in patients with primary colorectal cancer.

Czeiger D, Shaked G, Eini H, Vered I, Belochitski O, Avriel A, Ariad S, Douvdevani A.

Am J Clin Pathol. 2011 Feb;135(2):264-70. doi: 10.1309/AJCP4RK2IHVKTTZV.

PMID:
21228367
11.

Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.

Lazarovici TS, Mesilaty-Gross S, Vered I, Pariente C, Kanety H, Givol N, Yahalom R, Taicher S, Yarom N.

J Oral Maxillofac Surg. 2010 Sep;68(9):2241-7. doi: 10.1016/j.joms.2010.05.043.

PMID:
20728033
12.

Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial.

Eastell R, Lang T, Boonen S, Cummings S, Delmas PD, Cauley JA, Horowitz Z, Kerzberg E, Bianchi G, Kendler D, Leung P, Man Z, Mesenbrink P, Eriksen EF, Black DM; HORIZON Pivotal Fracture Trial..

Osteoporos Int. 2010 Jul;21(7):1277-85. doi: 10.1007/s00198-009-1077-9. Epub 2009 Oct 3.

13.

Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density.

Eastell R, Black DM, Boonen S, Adami S, Felsenberg D, Lippuner K, Cummings SR, Delmas PD, Palermo L, Mesenbrink P, Cauley JA; HORIZON Pivotal Fracture Trial..

J Clin Endocrinol Metab. 2009 Sep;94(9):3215-25. doi: 10.1210/jc.2008-2765. Epub 2009 Jun 30.

14.

Occupational exposure to solar UVB and seasonal monitoring of serum levels of 25-hydroxy vitamin D3: a case-control study.

Azizi E, Pavlotsky F, Vered I, Kudish AI.

Photochem Photobiol. 2009 Sep-Oct;85(5):1240-4. doi: 10.1111/j.1751-1097.2009.00569.x. Epub 2009 May 20.

PMID:
19500291
15.

Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.

Reid DM, Devogelaer JP, Saag K, Roux C, Lau CS, Reginster JY, Papanastasiou P, Ferreira A, Hartl F, Fashola T, Mesenbrink P, Sambrook PN; HORIZON investigators..

Lancet. 2009 Apr 11;373(9671):1253-63. doi: 10.1016/S0140-6736(09)60250-6.

PMID:
19362675
16.

Nurses' knowledge and perceptions about osteoporosis: a questionnaire survey.

Vered I, Werner P, Shemy G, Stone O.

Int J Nurs Stud. 2008 Jun;45(6):847-54. Epub 2007 Mar 23.

PMID:
17362958
17.

Peak bone mass in patients with phenylketonuria.

Modan-Moses D, Vered I, Schwartz G, Anikster Y, Abraham S, Segev R, Efrati O.

J Inherit Metab Dis. 2007 Apr;30(2):202-8. Epub 2007 Mar 8.

PMID:
17347917
18.

Plasma homocysteine levels in female patients with eating disorders.

Levine J, Gur E, Loewenthal R, Vishne T, Dwolatzky T, van Beynum IM, Sela BA, Vered I, Yosef G, Stein D.

Int J Eat Disord. 2007 Apr;40(3):277-84.

PMID:
17262817
19.

Time trends of incidence rates of thyroid cancer in Israel: what might explain the sharp increase.

Lubina A, Cohen O, Barchana M, Liphshiz I, Vered I, Sadetzki S, Karasik A.

Thyroid. 2006 Oct;16(10):1033-40.

PMID:
17042690
20.

Management of osteoporosis: a national survey of Israeli dietitians' knowledge and perceptions.

Stone O, Werner P, Ish-Shalom S, Vered I.

J Nutr Elder. 2005;25(1):83-97.

PMID:
16891264

Supplemental Content

Loading ...
Support Center